Title : Irinotecan pharmacokinetic and pharmacogenomic alterations induced by methylselenocysteine in human head and neck xenograft tumors.

Pub. Date : 2005 May

PMID : 15897249






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Methylselenocysteine/CPT-11 treatment, compared with CPT-11 alone, resulted in a significant decrease in levels of ABCC1 and DRG1 in FaDu tumors and an increase in levels of CYP3A5 and TNFSF6 in A253 tumors. Irinotecan ATP binding cassette subfamily C member 1 Homo sapiens
2 In conclusion, the significant increase in the cure rate after methylselenocysteine/CPT-11 could be related to increased drug delivery into both tumors (CES1), reduced resistance to SN-38 (ABCC1 and DRG1) in FaDu, and induced Fas ligand apoptosis (TNFSF6) in A253. Irinotecan ATP binding cassette subfamily C member 1 Homo sapiens
3 In conclusion, the significant increase in the cure rate after methylselenocysteine/CPT-11 could be related to increased drug delivery into both tumors (CES1), reduced resistance to SN-38 (ABCC1 and DRG1) in FaDu, and induced Fas ligand apoptosis (TNFSF6) in A253. Irinotecan ATP binding cassette subfamily C member 1 Homo sapiens